Medicare Enrolled

Dr. David Yin

Hematology & Oncology · Mesquite, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
4700 N GALLOWAY AVE, Mesquite, TX 75150
9726866411
In practice since 2016 (9 years)
NPI: 1992151153 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Yin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Yin

Dr. David Yin is a hematology & oncology in Mesquite, TX, with 9 years in practice. Based on federal Medicare data, Dr. Yin performed 27,233 Medicare services across 840 unique beneficiaries.

Between the years covered by Open Payments, Dr. Yin received a total of $2,494 from 38 pharmaceutical and/or device companies across 112 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Yin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 9 years in practice▲ Top 30% volume in TX$ $2,494 industry payments

Medicare Practice Summary

Medicare Utilization ↗
27,233
Medicare services
Top 30% in TX for hematology & oncology
840
Unique beneficiaries
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,026 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron sucrose injection (Venofer)9,000$0$2
Darbepoetin injection (Aranesp) for anemia7,975$2$20
Contrast dye for imaging (iodine-based)3,801$0$3
Anti-nausea injection (fosaprepitant)3,450$0$5
Dexamethasone injection (steroid)730$0$1
Injection, iron dextran, 50 mg339$13$43
Anti-nausea injection (Aloxi/palonosetron)260$1$114
Comprehensive metabolic blood panel168$10$64
Blood draw (venipuncture)165$8$20
Complete blood count (CBC) with differential150$8$36
Office visit, established patient (30-39 min)118$97$368
Injection of additional new drug or substance into vein109$12$108
Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session106$291$2,762
Drug injection, under skin or into muscle91$11$96
Administration of chemotherapy into vein, 1 hour or less84$104$707
Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev63$190$700
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less56$51$313
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour50$16$100
Ferritin level test (iron stores)48$13$60
Iron level test48$6$27
Iron binding capacity test48$9$35
Ct scan of chest with contrast38$54$821
Injection of drug or substance into vein38$29$247
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less36$23$157
Microscopic examination for white blood cells with manual cell count34$4$22
Complete blood count (CBC), automated34$6$34
Injection, diphenhydramine hcl, up to 50 mg31$1$7
Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev30$189$700
CT scan of abdomen and pelvis with contrast29$187$1,067
New patient office visit (45-59 min)29$100$565
Lactate dehydrogenase (enzyme) level27$6$31
Drawing of blood for a medical problem20$61$264
Office visit, established patient (20-29 min)15$62$250
CT scan of chest, without contrast13$54$686
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.5% high complexity
95.8% medium
3.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$2,494
Total received (2019-2024)
Avg $499/year across 5 years
Bottom 45% in TX for hematology & oncology
38
Companies
112
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,193 (87.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$301 (12.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,244
2023
$729
2022
$281
2020
$15
2019
$225

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$271
Novartis Pharmaceuticals Corporation
$208
AstraZeneca Pharmaceuticals LP
$159
Incyte Corporation
$158
Gilead Sciences, Inc.
$141
SOBI, INC
$137
Kyowa Kirin, Inc.
$125
Seattle Genetics, Inc.
$100
E.R. Squibb & Sons, L.L.C.
$93
Merck Sharp & Dohme LLC
$93
Daiichi Sankyo Inc.
$92
PharmaEssentia USA Corporation
$89
SANOFI-AVENTIS U.S. LLC
$85
Stemline Therapeutics Inc.
$81
GENZYME CORPORATION
$61
ABBVIE INC.
$60
PFIZER INC.
$57
Celgene Corporation
$54
Regeneron Healthcare Solutions, Inc.
$54
Janssen Biotech, Inc.
$44
Puma Biotechnology, Inc.
$33
Kite Pharma, Inc.
$29
Alexion Pharmaceuticals, Inc.
$26
Lilly USA, LLC
$23
Exelixis Inc.
$20
Eisai Inc.
$19
Myriad Genetic Laboratories, Inc.
$19
Sun Pharmaceutical Industries Inc.
$19
MorphoSys, US Inc.
$17
BeiGene USA, Inc.
$16
Rigel Pharmaceuticals, Inc.
$15
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
Genentech USA, Inc.
$14
Mirati Therapeutics, Inc.
$14
Takeda Pharmaceuticals U.S.A., Inc.
$14
Sirtex Medical Inc
$13
PUMA BIOTECHNOLOGY, INC.
$13
Astellas Pharma US Inc
$12
Top 3 companies account for 25.6% of total payments
Associated products mentioned in payments ›
ALUNBRIG · BESREMI · BLENREP · BRUKINSA · CABOMETYX · CALQUENCE · Doptelet · ELITEK · ENHERTU · EPKINLY · Enhertu · GAZYVA · GILOTRIF · IMFINZI · INLYTA · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · NERLYNX · OJJAARA · OPDIVO · OXBRYTA · Odomzo · Orserdu · PIQRAY · PLUVICTO · POTELIGEO · PRECISETUMOR · REBLOZYL · RYBREVANT · Rezlidhia · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · Vanflyta · XTANDI · Xtandi · YERVOY · Yescarta · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (88%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $9 per 100 Medicare services performed
Looking for a hematology & oncology in Mesquite?
Compare hematology & oncologys in the Mesquite area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
115
Per 100K population
4.4
County median income
$74,149
Nearest hospital
DALLAS REGIONAL MEDICAL CENTER
2.9 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Yin is a mixed practice specialist, with above-average Medicare volume (top 30% in TX), and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Yin experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Yin performed 9,000 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Yin receive payments from pharmaceutical companies?
Yes. Dr. Yin received a total of $2,494 from 38 companies across 112 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yin's costs compare to other hematology & oncologys in Mesquite?
Dr. Yin's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →